MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

511111

Report Date :

26.05.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

DIRUI INDUSTRIAL CO., LTD.

 

 

Registered Office :

No. 95 Yunhe Street New And Tech Development Zone Changchun Jilin Province, Pr

 

 

Country :

China

 

 

Financials (as on) :

31.12.2017

 

 

Date of Incorporation :

26.12.1994

 

 

Credibility Code :

91220101605902656F

 

 

Legal Form :

Shares Limited Co.

 

 

Line of Business :

The subject’s registered business scope includes technology development, technology transfer, technical consultation and technical service in the field of medical science and technology; manufacturing Class III 6840 clinical test analysis instrument, class III 6840 in vitro diagnostic reagent, class II 6840 clinical test analysis instrument, class II 6840 vitro diagnostic reagent; Class I 6840 clinical test analysis instrument and class I 6840 vitro diagnostic reagent; selling class I of medical instruments and Class II medical instruments: 6822 medical optical instruments, instruments and endoscope equipment, 6830 medical X ray equipment, 6833 medical radionuclide equipment, 6840 clinical test analysis instruments and diagnostic reagents, 6841 medical laboratory and basic equipment, 6866 medical polymer materials and products, Class III medial device: 6823 medical ultrasonic instrument and related equipment, 6825 medical high frequency instrument and equipment, 6828 medical magnetic resonance equipment, 6830 medical X ray equipment, 6840 clinical test analysis instrument and diagnostic reagent; selling raw and auxiliary materials and semi-finished products of self-produced products, raw and auxiliary materials, mechanical equipment, instruments and meters needed for scientific research; developing and selling software; after-sales service and leasing business of production and operation products.

 

 

No. of Employees :

1,769

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

 

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

                Previous Rating               

(30.09.2017)

Current Rating

(31.12.2017)

China

A2

A2

 

Risk Category

 

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

CHINA - ECONOMIC OVERVIEW

 

Since the late 1970s, China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role. China has implemented reforms in a gradualist fashion, resulting in efficiency gains that have contributed to a more than tenfold increase in GDP since 1978. Reforms began with the phaseout of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, growth of the private sector, development of stock markets and a modern banking system, and opening to foreign trade and investment. China continues to pursue an industrial policy, state support of key sectors, and a restrictive investment regime. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2016 stood as the largest economy in the world, surpassing the US in 2014 for the first time in modern history. China became the world's largest exporter in 2010, and the largest trading nation in 2013. Still, China's per capita income is below the world average.

 

After keeping its currency tightly linked to the US dollar for years, China in July 2005 moved to an exchange rate system that references a basket of currencies. From mid-2005 to late 2008, the renminbi appreciated more than 20% against the US dollar, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing announced it would allow a resumption of gradual liberalization. From 2013 until early 2015, the renminbi (RMB) appreciated roughly 2% against the dollar, but the exchange rate fell 13% from mid-2015 until end-2016 amid strong capital outflows in part stemming from the August 2015 official devaluation; in 2017 the RMB resumed appreciating against the dollar – roughly 7% from end-of-2016 to end-of-2017. From 2013 to 2017, China had one of the fastest growing economies in the world, averaging slightly more than 7% real growth per year. In 2015, the People’s Bank of China announced it would continue to carefully push for full convertibility of the renminbi, after the currency was accepted as part of the IMF’s special drawing rights basket. However, since late 2015 the Chinese Government has strengthened capital controls and oversight of overseas investments to better manage the exchange rate and maintain financial stability.

 

The Chinese Government faces numerous economic challenges including: (a) reducing its high domestic savings rate and correspondingly low domestic household consumption; (b) managing its high corporate debt burden to maintain financial stability; (c) controlling off-balance sheet local government debt used to finance infrastructure stimulus; (d) facilitating higher-wage job opportunities for the aspiring middle class, including rural migrants and college graduates, while maintaining competitiveness; (e) dampening speculative investment in the real estate sector without sharply slowing the economy; (f) reducing industrial overcapacity; and (g) raising productivity growth rates through the more efficient allocation of capital and state-support for innovation. Economic development has progressed further in coastal provinces than in the interior, and by 2016 more than 169.3 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of China’s population control policy known as the “one-child policy” - which was relaxed in 2016 to permit all families to have two children - is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and urbanization. The Chinese Government is seeking to add energy production capacity from sources other than coal and oil, focusing on natural gas, nuclear, and clean energy development. In 2016, China ratified the Paris Agreement, a multilateral agreement to combat climate change, and committed to peak its carbon dioxide emissions between 2025 and 2030.

 

The government's 13th Five-Year Plan, unveiled in March 2016, emphasizes the need to increase innovation and boost domestic consumption to make the economy less dependent on government investment, exports, and heavy industry. However, China has made more progress on subsidizing innovation than rebalancing the economy. Beijing has committed to giving the market a more decisive role in allocating resources, but the Chinese Government’s policies continue to favor state-owned enterprises and emphasize stability. Chinese leaders in 2010 pledged to double China’s GDP by 2020, and the 13th Five Year Plan includes annual economic growth targets of at least 6.5% through 2020 to achieve that goal. In recent years, China has renewed its support for state-owned enterprises in sectors considered important to "economic security," explicitly looking to foster globally competitive industries. Chinese leaders also have undermined some market-oriented reforms by reaffirming the “dominant” role of the state in the economy, a stance that threatens to discourage private initiative and make the economy less efficient over time. The slight acceleration in economic growth in 2017—the first such uptick since 2010—gives Beijing more latitude to pursue its economic reforms, focusing on financial sector deleveraging and its Supply-Side Structural Reform agenda, first announced in late 2015.

 

Source : CIA

 

 


Company name & address

 

Company Name            :           DIRUI INDUSTRIAL CO., LTD.

Address                       :           NO. 95 YUNHE STREET NEW AND TECH DEVELOPMENT ZONE

CHangchun jilin PROVINCE, PR CHINA

Telephone                    :           0086- 431-85100409

Facsimile                     :           0086- 431-85173354

Website                        :           http://www.dirui.com.cn/cn/

Email                           :           dirui.china@dirui.com.cn

 

 

REGISTRATION INFORMATION

 

Established Date       :  1994-12-26

Credibility Code        :  91220101605902656F

Legal Form                :  Shares Limited Co.

Registration Authority: Administration for Industry & Commerce (AIC) – High-Tech Industrial Development Zone Branch, Changchun

Status                        :  Active

 

Registered Capital     :  RMB 153,350,000

Paid-up capital          :  RMB 153,350,000

Turnover                   :  RMB 867,690,000 (Consolidated as of Dec. 31, 2017)

Equities                    :  RMB 1,414,344,000 (Consolidated as of Dec. 31, 2017)

 

Chief Executive         :  Song Yong

Business Line           :  Manufacturer

Manpower                 :  1,769

 

Tax Registration

Certificate No.           : 91220101605902656F

Organization Code    : 60590265-6

 

HS code                     : 2201360001

Import & Export code: 2201605902656

 

Financial Condition   :  Fairly good

Business Size           :  Large Enterprise

Payment                    :  Regular

 

 

Registered Address

 

NO. 95 YUNHE STREET NEW AND TECH DEVELOPMENT ZONE CHANGCHUN JILIN PROVINCE, PR CHINA

 

 

Company Status: Shares limited co.

 

This form of business in PR China is defined as a legal person. Its registered capital is divided into shares of equal par value and the co. raises capital by issuing share certificates by promotion or by public offer. Shareholders bear limited liability to the extent of shareholding, and the co. is liable for its debts only to the extent of its total assets. The co has independent property of legal person and enjoys property rights of legal person. The characteristics of the shares limited co. are as follows:

The establishment of the co. requires at least two promoters and no more than 200, half of whom shall be domiciled in China. Natural person are allowed to serve as promoters.

The minimum registered capital of a co. is RMB 5M. while that of the co. with foreign investment is RMB 5M. The total capital of a co. which propose to apply for publicly listed must be no less than RMB 30M.

The board of directors must consist of five to nineteen directors.

If the co. raises capital by public offer, the promoters must not subscribe less than 35% of the total shares. the promoters’ shares are restricted to transfer- within one year of the offer.

A state-owned enterprise that is restructured into a shares limited co. must comply with the conditions & requirements specified under the law & administrative rule.

 

 

Premise

The subject operates from premises located at the heading address, and this address houses its operating office and factory in Changchun. Our checks reveal that the subject owns the total premise, but the square meters are unknown.

 

 

MANAGEMENT

 

Position

Name

 

Nationality

Legal representative, Chairman

Song Yong

Chinese

General Manager

Song Jie

 

Vice General Manager

Li Jing

He Haohui

Zheng Guoming

Chinese

Directors

Song Jie

Zhang Wen

Sun Chengyan

Liu Ning

Zhi Li

Xu Shan

Chinese

Supervisors

Yu Ge

Wang Ludi

Wang Yunli

Chinese

 

 

 

 

MAJOR SHAREHOLDERS

 

Name   (As of 2018-03-31)                                                                                 % Shareholding

 

Changchun Ruifa Investment Co., Ltd.                                                                            53.8

Song Jie                                                                                                                       7.07

Song Yong                                                                                                                   6.7

Shaanxi International Trust co Ltd - Shaan Guo tou chi Ying 53 securities investment collective fund trust scheme

1.98

Central Huijin Asset Management Co., Ltd.                                                                     1.01

Shanghai Qian Rong Asset Management Co., Ltd. - Private Fund Of Qian Sheng                         20.76

Han Bing                                                                                                                       0.55

Shanghai Qian Rong Asset Management Co., Ltd. - Private Fund Of Qian Sheng                         40.54

Xiang Yang                                                                                                                   0.44

Zhang Yi                                                                                                                       0.43

 

Other Shareholders                                                                                                        26.72

 

Changchun Ruifa Investment Co., Ltd.

------------------------------------------

Credibility Code: 91220102697761837B

Legal representative: Song Yong 宋勇  

Registered Capital: RMB 25,000,000

Established Date: 2010-01-20

 

 

KEY EVENTS

 

Changes of its registered information are as follows:

 

Date of change

Item

Before the change

After the change

2017-05-11

Company name

CHANGCHUN

DIRUI INDUSTRIAL CO LTD

Present one

2015-05-11

Registered capital

RMB 61,340,000

Present one

2014-09-24

Registered capital

RMB 46,000,000

RMB 61,340,000

2010-09-28

Registered capital

RMB 43,000,000

RMB 46,000,000

2010-07-29

Company Chinese name

CHANGCHUN

DIRUI INDUSTRIAL CO LTD

CHANGCHUN

DIRUI INDUSTRIAL CO LTD 

2010-07-29

Registered capital

RMB 30,244,790

RMB 43,000,000

2010-06-28

Registered capital

RMB 30,000,000

RMB 30,244,790

 

 

BUSINESS OPERATIONS

 

The subject’s registered business scope includes technology development, technology transfer, technical consultation and technical service in the field of medical science and technology; manufacturing Class III 6840 clinical test analysis instrument, class III 6840 in vitro diagnostic reagent, class II 6840 clinical test analysis instrument, class II 6840 vitro diagnostic reagent; Class I 6840 clinical test analysis instrument and class I 6840 vitro diagnostic reagent; selling class I of medical instruments and Class II medical instruments: 6822 medical optical instruments, instruments and endoscope equipment, 6830 medical X ray equipment, 6833 medical radionuclide equipment, 6840 clinical test analysis instruments and diagnostic reagents, 6841 medical laboratory and basic equipment, 6866 medical polymer materials and products, Class III medial device: 6823 medical ultrasonic instrument and related equipment, 6825 medical high frequency instrument and equipment, 6828 medical magnetic resonance equipment, 6830 medical X ray equipment, 6840 clinical test analysis instrument and diagnostic reagent; selling raw and auxiliary materials and semi-finished products of self-produced products, raw and auxiliary materials, mechanical equipment, instruments and meters needed for scientific research; developing and selling software; after-sales service and leasing business of production and operation products.

 

The subject is mainly engaged in manufacturing and selling medical device.

 

Products:

 

CHEMISTRY ANALYZER

CS-6400 Auto-Chemistry System

CS-1600 Auto-Chemistry Analyzer

CS-1300B Auto-Chemistry Analyze

CS-1200 Auto-Chemistry Analyzer

CS-600B Auto-Chemistry Analyzer

CS-400 Auto-Chemistry Analyzer

CS-300B Auto-Chemistry Analyzer

CS-T240 Auto-Chemistry Analyzer

DR-7000D Semi-Automatic Chemistry Analyzer

 

HEMATOLOGY ANALYZER

BF-6880 Automatic Hematology Analyzer

BF-6800 Automatic Hematology Analyzer

BF-6500 Automatic Hematology Analyzer

BCC-3600 Hematology Analyzer

 

URINE ANALYZER

Automatic Urinalysis System(FUS-200/H-800)

Automatic Urinalysis System(FUS-100/H-800)

FUS-2000 Urinalysis Hybrid

FUS-200 Urine Sediment Analyzer

FUS-100 Urine Sediment Analyzer

H-800 Automatic Urine Analyzer

H-500 Urine Analyzer

H-100 Urine Analyzer

 

REAGENTS AND CONSUMABLES

Hematology Control and Calibration

Urinalysis Strips

Urinalysis Control

Automatic Urine Analyzer Detergent

Urine Sediment Analyzer Reagent

Hematology Analyzer Reagent

Chemistry Reagent [ 7020 ]

Chemistry Control and Calibration Serum

Chemistry Analyzer Detergent

 

ISE Reagent

 

The subject sources its materials 60% from domestic market, and 40% from overseas market. the subject sells 30% of its products in domestic market, and 70% to overseas market, mainly Argentina, Ecuador, etc.

 

The buying terms of the subject include Check, T/T, L/C and Credit of 30-60 days. The payment terms of the subject include Check, T/T, L/C and Credit of 30-60 days.

 

 

SUPPLIER & CUSTOMER

 

*Major customer:

 

Inmunochem Sac (Peru)

Bioter Diagnostica S.A.S. (Colombia)

 

Etc.

 

 

RELATED COMPANIES

 

Subsidiaries

 

Uray Bio Med Shenzhen co., Ltd

========================

Credibility Code: 91440300MA5DERF2X4

Legal representative: Zheng Zehui

Registered Capital: RMB 20,000,000

Established Date: 2016-06-17

 

Shenzhen Dirui Industrial Co., Ltd

========================

Credibility Code: 91440300MA5D8Y40X9

Legal representative: Song Jie

Registered Capital: RMB 20,000,000

Established Date: 2016-03-22

 

Etc.

 

 

Branches

 

Dirui Industrial Co Ltd Liaoning Branch

========================

 

 

Credibility Code: 91210102MA0UT2GK3F

Principal: Wang Shukun

Established Date: 2017-12-19

 

Etc.

 

 

NEGATIVE INFORMATION

 

Lawsuit Record:   No record.

 

Trade payment experience: The subject did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record:     None in our database.

 

Debt collection record: No overdue amount owed by the subject was placed to us for collection within the last 6 years.

 

Customs administrative penalty: No record.

 

Equity freeze information: No record.

 

Administrative Penalty: No record.

 

MORTGAGE

 

There is no record of mortgage information at present.

 

 

TRADEMARK

 

Registration No.

Registration Date

Trademark Design

5944910

2007-03-16

5354469

2006-05-17

Etc.

 

 

PATENT

 

Patent name

Published Application Number

Application number

Date of publication

A kind of ventilated and leakproof bottle cap

CN206537703U

CN201621012521.X

2017-10-03

A supply device and method for a container

CN105628946B

CN201511023867.X

2017-09-01

 

Etc.

 

 

BANKING

 

The subject declined to release its banking details.

 

 

ABBREVIATED FINANCIAL STATEMENT

 

Consolidated Balance Sheet

Unit: RMB’000

 

   as of Dec. 31, 2016

 as of Dec. 31, 2017

Cash & bank

230,070

193,334

Inventory

156,209

185,646

Accounts receivable

151,109

160,933

Advances to suppliers

12,630

13,919

Other receivables

35,346

26,905

Interest receivable

244

0

Non-current assets due within one year

42

0

Other current assets

157,393

160,222

 

------------------

------------------

Current assets

743,043

740,959

Available-for-sale financial assets

67,117

66,863

Investment real estate

0

24,498

Fixed assets net value

318,000

305,684

Projects under construction

10,974

0

Intangible assets

300,966

278,534

Development expenses

14,318

24,992

Goodwill

397,195

397,195

Long-term prepaid expenses

20

751

Deferred tax assets

2,328

2,432

Other assets

4,392

9,102

 

------------------

------------------

 

Total assets

1,858,353

1,851,010

 

=============

=============

Short loans

100,000

36,000

Notes payable

10,174

17,029

Accounts payable

52,092

64,085

Advances from customers

32,549

39,224

Accrued payroll

30,932

34,870

Taxes payable

23,396

15,557

Other accounts payable

5,531

7,680

Non-current liabilities due within one year

69,500

50,000

Other current liabilities

2

104,559

 

-----------------

-----------------

Current liabilities

324,176

369,004

Non- current liabilities

158,123

67,662

 

------------------

------------------

Total liabilities

482,299

436,666

Shareholders equities

1,376,054

1,414,344

 

------------------

------------------

Total liabilities & equities

1,858,353

1,851,010

 

=============

=============

 

Consolidated Income Statement

Unit: RMB’000

 

   as of Dec. 31, 2016

  as of Dec. 31, 2017

Turnover

758,694

867,690

Cost of goods sold

283,708

309,896

     Sales expense

138,416

151,004

     Management expense

170,020

176,887

     Finance expense

3,337

10,916

Profit before tax

181,111

242,756

Less: profit tax

23,591

31,627

Net profit

157,520

211,129

 

Important Ratios

=============

 

as of Dec. 31, 2016

as of Dec. 31, 2017

*Current ratio

2.29

2.01

*Quick ratio

1.81

1.50

*Liabilities to assets

0.26

0.24

*Net profit margin (%)

20.76

24.33

*Return on total assets (%)

8.48

11.41

*Inventory /Turnover ×365

76 days

79 days

*Accounts receivable/Turnover ×365

73 days

68 days

*Turnover/Total assets

0.41

0.47

* Cost of goods sold/Turnover

0.37

0.36

 

 

PROFITABILITY: FAIRLY GOOD

l  The turnover of the subject is fairly good.

l  The subject’s net profit margin is fairly good.

l  The subject’s return on total assets is fairly good.

l  The subject’s cost of goods sold is low, comparing with its turnover.

 

 

LIQUIDITY: FAIRLY GOOD

l  The current ratio of the subject is maintained in a fairly good level.

l  The subject’s quick ratio is maintained in a fairly good level.

l  The inventory of the subject is average.

l  The accounts receivable of the subject is average.

l  The short-term loan of the subject is average.

l  The subject’s turnover is in a fair level, comparing with the size of its total assets.

 

 

LEVERAGE: FAIRLY GOOD

l  The debt ratio of the subject is low.

l  The risk for the subject to go bankrupt is average.

 

 

TREND ANALYSIS

===========

 

2015

2016

2017

Sales Trend

--

--

Ç

Profit margin

--

--

Ç

Debt to assets ratio

--

--

È

Overall Financial Condition

□Good                   ■Fairly Good           □Stable         

□Fairly Stable       □Fair                        □Poor  

 

 

COMMENT

 

The subject was registered as a Shares limited co. at local Administration for Industry & Commerce (AIC - The official body of issuing and renewing business license). The subject is considered large-sized in its line with fairly good financial conditions.

 

 

 

 

 

 


 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 68.26

UK Pound

1

INR 91.22

Euro

1

INR 79.88

CNY

1

INR 10.60

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

NIS

 

 

Report Prepared by :

TPT

 


 

RATING EXPLANATIONS

 

Credit Rating

 

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.